Stocks and Investing Stocks and Investing
Thu, October 5, 2023
Wed, October 4, 2023
Tue, October 3, 2023

Edward Tenthoff Maintained (SYRS) at Buy with Decreased Target to $7 on, Oct 3rd, 2023


Published on 2024-10-28 06:41:40 - WOPRAI, Edward Tenthoff
  Print publication without navigation


Edward Tenthoff of Piper Sandler, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $11 to $7 on, Oct 3rd, 2023.

Edward has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Edward's Rating of Hold.



This is the rating of the analyst that currently disagrees with Edward


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Wednesday, August 9th, 2023